World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
18716
World Ranking
2251
National Ranking
192

Alasdair P. MacGowan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alasdair P. MacGowan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 340 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Alasdair P. MacGowan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alasdair P. MacGowan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Alasdair P. MacGowan is affiliated with North Bristol NHS Trust in the United Kingdom. Their research spans multiple fields related to medicine, including biochemistry, genetics, and molecular biology, with a particular emphasis on applied microbiology and biotechnology, infectious diseases, pharmacology, and epidemiology.

MacGowan has contributed extensively to the understanding of antimicrobial resistance, antibiotic pharmacokinetics, and the efficacy of antibiotics. Their work also addresses bacterial identification and susceptibility testing, pneumonia and respiratory infections, and clinical research related to COVID-19.

Some of the recent papers authored or co-authored by MacGowan include:

  • Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study, 2023, published in PLoS Medicine
  • Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort, 2020, published in Journal of Infection
  • Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper, 2020, published in Clinical Microbiology and Infection
  • Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study, 2021, published in Emergency Medicine Journal
  • Clinical and cost effectiveness of single stage compared with two stage revision for hip prosthetic joint infection (INFORM): pragmatic, parallel group, open label, randomised controlled trial, 2022, published in BMJ

Frequent co-authors who have collaborated with MacGowan include:

  • Marie Attwood
  • Fergus Hamilton
  • Alan Noel
  • Karen E. Bowker
  • David Arnold

The main publication venues for their research are:

  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Journal of Infection
  • Medicine

The major fields of study associated with MacGowan's work are:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields within these areas where MacGowan has multiple publications include:

  • Epidemiology
  • Pharmacology
  • Molecular Medicine
  • Infectious Diseases
  • Applied Microbiology and Biotechnology

Key topics in MacGowan's research cover:

  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Antimicrobial Resistance in Staphylococcus
  • COVID-19 Clinical Research Studies

Best Publications

  • The global threat of antimicrobial resistance: science for intervention

    Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet

  • Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

    Kenneth N. Agwuh;Alasdair MacGowan

  • EUCAST expert rules in antimicrobial susceptibility testing

    R. Leclercq;R. Cantón;D.F.J. Brown;C.G. Giske

  • Development of the quinolones.

    Monique I. Andersson;Alasdair P. MacGowan

  • The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria : report from the EUCAST Subcommittee

    M J Ellington;O Ekelund;Frank Møller Aarestrup;R Canton

  • A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

    M Wootton;R A Howe;R Hillman;T R Walsh

  • European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

    Gunnar Kahlmeter;Derek F. J. Brown;Fred W. Goldstein;Alasdair P. MacGowan

  • Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

    Timothy R. Walsh;Anne Bolmström;Anette Qwärnström;Phion Ho

  • Antibiotic treatment of gram-positive bone and joint infections.

    Elizabeth S. R. Darley;Alasdair P. MacGowan

  • Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

    Alasdair P MacGowan

  • The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

    J.W. Mouton;D.F.J. Brown;P. Apfalter;R. Cantón

  • European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

    G Kahlmeter;Dfj Brown;FW Goldstein;AP MacGowan

  • Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests

    Alasdair P. MacGowan;Richard Wise

  • Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

    Johan W Mouton;Paul G Ambrose;Rafael Canton;George L Drusano

  • Vancomycin-resistant Staphylococcus aureus

    Unknown

  • Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

    A. M. Lovering;J. Zhang;G. C. Bannister;B. J. A. Lankester

  • Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia

    Timothy R. Walsh;Len Hall;Stephen J. Assinder;Wright W. Nichols

  • The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources

    Alasdair P. MacGowan;Karen Bowker;James McLauchlin;Peter M. Bennett

  • Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001–2002: the BSAC Bacteraemia Resistance Surveillance Programme

    Rosy Reynolds;Nicola Potz;Melissa Colman;Andrea Williams

  • Continuous Infusion of β-Lactam Antibiotics

    Alasdair P. MacGowan;Karen E. Bowker

  • Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia.

    T R Walsh;A P MacGowan;P M Bennett

  • Why monitor peak vancomycin concentrations?

    Unknown

Frequent Co-Authors

Timothy R. Walsh
Timothy R. Walsh University of Oxford
Peter M. Bennett
Peter M. Bennett University of Bristol
Jonathan A C Sterne
Jonathan A C Sterne University of Bristol
Paul Little
Paul Little University of Southampton
Michael T. Lawton
Michael T. Lawton Barrow Neurological Institute
Leonard Leibovici
Leonard Leibovici Tel Aviv University
Gunnar Kahlmeter
Gunnar Kahlmeter Uppsala University
Christian G. Giske
Christian G. Giske Karolinska University Hospital
Rafael Cantón
Rafael Cantón Instituto Ramón y Cajal de Investigación Sanitaria
Johan W. Mouton
Johan W. Mouton Radboud University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related online degrees and career paths in the healthcare and medical fields. For those interested in administrative roles, programs like the fastest online medical billing and coding certificate programs offer efficient pathways to enter the medical billing sector with flexible study options.

Additionally, students seeking a broader healthcare education can explore a range of online healthcare programs that provide valuable clinical and administrative knowledge applicable to microbiology-related careers.

For those aiming toward public health, the best easiest mph online programs to get into represent an accessible option to expand expertise in epidemiology and disease prevention, closely linked to microbiology applications.

Career pathways also include specialized roles such as child life specialists, who support young patients in healthcare settings. Understanding how much do child life specialists make can help guide career decisions when combining microbiology knowledge with child-focused healthcare services.

Best Scientists Citing Alasdair P. MacGowan

Trending Scientists

Recently Published Articles